Back to Top Skip to main content Skip to sub-navigation

Brief Report: Medical Encounters for Snakebite Envenomation, Active and Reserve Components, U.S. Armed Forces, 2016–2020

Image of Masters of camouflage, the Sidewinder Rattlesnakes are out and about aboard Marine Corps Logistics Base Barstow, California, May 11. Watch where you put your hands and feet, and observe children and pets at all times, as this is the natural habitat for these venomous snakes and a bite can cause serious medical problems. Notice the sharp arrow-shaped head with pronounced jaws, and the raised eye sockets, as well as the telltale rattles. Keep in mind, however, that rattles can be broken or lost, so you may or may not hear a rattle before they strike to protect themselves. Click to open a larger version of the image. Masters of camouflage, the Sidewinder Rattlesnakes are out and about aboard Marine Corps Logistics Base Barstow, California, May 11. Watch where you put your hands and feet, and observe children and pets at all times, as this is the natural habitat for these venomous snakes and a bite can cause serious medical problems. Notice the sharp arrow-shaped head with pronounced jaws, and the raised eye sockets, as well as the telltale rattles. Keep in mind, however, that rattles can be broken or lost, so you may or may not hear a rattle before they strike to protect themselves.

Recommended Content:

Medical Surveillance Monthly Report

Background

Of the approximately 3,000 known snake species in the world, about 20% (i.e., 600 species) are venomous.1 Snakebite envenomation (SBE) occurs when venom is injected into a human or animal via a snake's fangs, or much less frequently, via spitting venom into a victim's eye or open wound. Not all snakebites result in envenomation; an estimated 25% to 50% of snakebites are "dry bites" in which an insufficient amount of venom is injected to cause clinical symptoms.2,3 Clinical effects of snake envenomation can range from mild local effects (e.g., superficial puncture wounds, pain and swelling) to more severe complications including permanent disability and death.3

SBEs are a significant public health issue especially in the tropical and subtropical areas of Africa, Asia, and Latin America.4 In 2017, the World Health Organization (WHO) identified SBE as a neglected tropical disease. WHO estimates between 1.8-2.7 million SBEs occur annually, resulting in an estimated 81,410 to 137,880 deaths.5 Each year in the U.S., there are an estimated 5,000-10,000 SBEs and fewer than 10 associated deaths.6

Although rare, SBEs are an occupational hazard for military members worldwide. The recent published literature on SBE in military members is sparse. During contingency operations in Iraq and Afghanistan, self-reported incidence of snakebite in U.S. troops was 4.9 snakebites per 10,000 person-months.7 A recent review of snakebites treated between 2015-2017 by the French military health service in overseas locations identified only two soldiers (1 French, 1 Dutch) treated for SBE in Mali, both of whom were treated with antivenom and recovered fully.8 A 2018 summary of snakebites in UK personnel focused on Europe and Africa and reported on an envenomation in a UK service member bitten by a horned viper in Croatia. This summary also highlighted that the majority of SBE cases treated by military medical providers occurred among local civilians.9 The only death attributed to SBE in a U.S. service member that was reported in the lay press occurred in 2015 in Kenya.10

No comprehensive summary of all medically diagnosed SBEs in U.S. service members worldwide has been published. This analysis summarizes the incidence of SBE in active and reserve component service members identified through review of administrative medical data. This analysis also provides a breakdown of SBEs by demographic and military characteristics including the country and combatant command in which the SBEs were treated.

Methods

The surveillance period was from 1 January 2016 through 31 December 2020. The surveillance population included all individuals who served in the active or reserve component of the U.S. Army, Navy, Air Force, or Marine Corps at any time during the surveillance period. The Defense Medical Surveillance System (DMSS) was searched for all inpatient, outpatient and/ or theater medical encounters that contained any of the ICD-10 codes falling under the parent code T63.0 ("Toxic effect of snake venom") in any diagnostic position. Because ICD-9 diagnoses still appear in the theater medical encounter data, service members could also qualify as a case if they had a diagnosis of ICD-9: 989.5 ("Toxic effect of venom") or E905.0 ("Venomous snakes and lizards causing poisoning and toxic reactions"). The patient assessment field was reviewed for these ICD-9 coded records to determine whether the injury was caused by a snake, and only the records for injuries that were caused by snakes were retained. A service member could be counted as an incident case once per year. The location of the SBE was determined by mapping the treating facility for the SBE to a specific country and combatant command.

Results

During the 5-year surveillance period, a total of 345 SBEs were diagnosed in U.S. service members. Approximately 90% of cases were among male service members and about 45% occurred in soldiers. More than three-quarters of SBEs were diagnosed among active component service members (Table). The majority of cases occurred in service members in the 20-29 year old age group. Service members in the repair/engineering and combat-specific occupational groups were the most frequently affected by SBEs and constituted over half of all SBEs during the period (Table).

The annual numbers of SBEs were at their highest in 2017 (n=83); this peak represented a 9.2% increase in SBEs over the prior year. Total SBEs declined by 22.6% in 2018 and a further 9.4% in 2019; 2019 had the lowest number of incident cases of SBE during the surveillance period (n=58). Incident cases increased by 10.3% in 2020 (n=64) which was the same level as 2018 (Figure 1). Overall, 59.4% (n=205) of the cases occurred between the months of June and September (Figure 2).

Most SBE cases (96.2%) were diagnosed in the U.S.; consequently, almost 96% of cases occurred in the U.S. Northern Command (Table). Cases diagnosed in Hawaii are attributed to the U.S. IndoPacific Command. Counts of cases by specific location were 1 in Puerto Rico, 330 in the U.S. (excluding Hawaii), 5 in Guam, 4 in Japan, 2 in Korea, 2 in Hawaii, and 1 with an unknown location.

Editorial Comments

This analysis demonstrates that the vast majority of medically diagnosed SBEs in U.S. service members during 2016-2020 occurred in the U.S. In accordance with the findings of a recent report on the epidemiology of snakebites in the U.S., male service members were disproportionately affected by SBEs.6

This analysis is subject to the same limitations as any analysis of administrative medical data. Only SBEs that were diagnosed by a medical provider and entered into a service member's electronic medical record could be included in this analysis. An SBE could also be missed due to miscoding or because medical care for an SBE was not documented in the medical record.

In the U.S., service member SBEs occur more frequently during warm weather months. Preventive measures for avoiding SBE include precautions such as avoiding snakes in the wild, wearing long pants or boots when working or walking outdoors, and wearing gloves when handling brush or reaching into areas that might house snakes. Anyone bitten by a snake should seek medical attention as soon as possible.11,12

Although this analysis demonstrates that the majority of service members' SBEs occur in the U.S., appropriate precautions should be taken to avoid SBE during deployment outside of the U.S. Planning for deployment should include education in the medically important snake species and the appropriate medical management of snakebites specific to deployment location. In 2020, the Joint Trauma System published a Clinical Practice Guideline for Global Snake Envenomation Management (CPG ID:81) which provides a comprehensive guide to snakebite management by combatant command.12

References

  1. Venemous snakes distribution and species risk categories. World Health Organization. Accessed 08 May 2021. https://apps.who.int/bloodproducts/snakeantivenoms/database/
  2. Pucca MB, Knudsen C, S Oliveira I, et al. Current Knowledge on Snake Dry Bites. Toxins (Basel). 2020;12(11):668.
  3. Joint Trauma System Clinical Practice Guideline: Global Snake Envenomation Management. Accessed 08 May 2021. https://jts.amedd.army.mil/assets/docs/cpgs/Global_Snake_Envenomation_Management_30_Jun_2020_ID81.pdf
  4. Kasturiratne A, Wickremasinghe AR, de Silva N, Gunawardena NK, Pathmeswaran A, Premaratna R, et al. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med. 2008;5(11):e218.
  5. World Health Organization. Snake bite envenomation. 2019. World Health Organization. Accessed April 29, 2020. https://www.who.int/news-room/fact-sheets/detail/snakebite-envenoming
  6. Greene SC, Folt J, Wyatt K, Brandehoff NP. Epidemiology of fatal snakebites in the United States 1989-2018. Am J Emerg Med. 2020 Aug 29:S0735-6757(20)30777-30784.
  7. Shiau DT, Sanders JW, Putnam SD, et al. Selfreported incidence of snake, spider, and scorpion encounters among deployed U.S. military in Iraq and Afghanistan. Mil Med. 2007;172(10):1099-1102.
  8. Bomba A, Favaro P, Haus R, et al. Review of Scorpion Stings and Snakebites Treated by the French Military Health Service During Overseas Operations Between 2015 and 2017. Wilderness Environ Med. 2020;31(2):174-180.
  9. Wilkins D, Burns DS, Wilson D, Warrell DA, Lamb LEM. Snakebites in Africa and Europe: a military perspective and update for contemporary operations. J R Army Med Corps. 2018 Sep;164(5):370-379.
  10. Montgomery, Nancy. Soldier died of venomous snake bite, autopsy confirms. Stars and Stripes. March 15, 2015. Accessed May 08, 2021. https://www.stripes.com/news/soldier-died-of-venomous-snake-bite-autopsy-confirms-1.334382
  11. Torpy JM, Schwartz LA, Golub RM. JAMA patient page. Snakebite. JAMA. 2012;307(15):1657.

FIGURE 1. Annual counts of incident cases of snakebite envenomations, by sex, active and reserve component service members, U.S. Armed Forces, 2016–2020

FIGURE 2. Cumulative number of incident snakebite envenomations, by month, active and reserve component service members, U.S Armed Forces, 2016–2020

TABLE. Demographic and military characteristics of incident cases of snakebite envenomation, U.S. Armed Forces, 2016–2020

You also may be interested in...

Obesity prevalence among active component service members prior to and during the COVID-19 pandemic, January 2018–July 2021

Article
3/1/2022

This study examined monthly prevalence of obesity and exercise in active component U.S. military members prior to and during the COVID-19 pandemic. These results suggest that the COVID-19 pandemic had a small effect on the trend of obesity in the active component U.S. military and that obesity prevalence continues to increase.

Recommended Content:

Medical Surveillance Monthly Report

Update: Malaria, U.S. Armed Forces, 2021

Article
3/1/2022

Malaria infection remains an important health threat to U.S. service members who are located in endemic areas because of long-term duty assignments, participation in shorter-term contingency operations, or personal travel. In 2021, a total of 20 service members were diagnosed with or reported to have malaria.

Recommended Content:

Medical Surveillance Monthly Report

Surveillance Snapshot: Medical Separation from Service Among Incident Cases of Osteoarthritis and Spondylosis, Active Component, U.S. Armed Forces, 2016–2020

Article
3/1/2022
Marines hike to the next training location during Exercise Baccarat in Aveyron, Occitanie, France, Oct.16, 2021. Exercise Baccarat is a three-week joint exercise with Marines and the French Foreign Legion that challenges forces with physical and tactical training. Photo By: Marine Corps Lance Cpl. Jennifer Reyes

Osteoarthritis (OA) is the most common adult joint disease and predominantly involves the weight-bearing joints. This condition, including spondylosis (OA of the spine), results in significant disability and resource utilization and is a leading cause of medical separation from military service.

Recommended Content:

Medical Surveillance Monthly Report

Brief Report: Refractive Surgery Trends at Tri-Service Refractive Surgery Centers and the Impact of the COVID-19 Pandemic, Fiscal Years 2000–2020

Article
3/1/2022
Cadet Saverio Macrina, U.S. Military Academy West Point, receives corneal cross-linking procedure at Fort Belvoir Community Hospital, Va., Nov. 21, 2016. (DoD photo by Reese Brown)

Since the official introduction of laser refractive surgery into clinical practice throughout the Military Health System (MHS) in fiscal year 2000, these techniques have been heavily implemented in the tri-service community to better equip and improve the readiness of the U.S. military force.

Recommended Content:

Medical Surveillance Monthly Report

Brief report: Using syndromic surveillance to monitor MIS-C associated with COVID-19 in Military Health System beneficiaries

Article
3/1/2022
Air Force 1st Lt. Anthony Albina, a critical care nurse assigned to Joint Base Andrews, Md., checks a patient’s breathing and heart rate during an intubation procedure while supporting COVID-19 response operations in Cleveland, Jan. 20, 2022.

SARS CoV-2 and the illness it causes, COVID-19, have exacted a heavy toll on the global community. Most of the identified disease has been in the elderly and adults. The goal of this analysis was to ascertain if user-built ESSENCE queries applied to records of outpatient MHS health care encounters are capable of detecting MIS-C cases that have not been identified or reported by local public health departments.

Recommended Content:

Medical Surveillance Monthly Report

Diagnosis of hepatitis C infection and cascade of care in the active component, U.S. Armed Forces, 2020

Article
2/1/2022
Navy Petty Officer 2nd Class Cecil Dorse, left, and Navy Petty Officer 3rd Class Janet Rosas test blood samples aboard the Military Sealift Command hospital ship USNS Comfort while the ship is in New York City in support of the nation’s COVID-19 response, April 6, 2020. Photo By: Navy Petty Officer 2nd Class Sara Eshleman

Hepatitis C virus (HCV) infection rates are rising in the U.S. despite widely available tools to identify and effectively treat nearly all of these cases. This cross-sectional study aimed to use laboratory data to evaluate the prevalence of HCV diagnoses among active component U.S. military service members.

Recommended Content:

Medical Surveillance Monthly Report

A new approach to categorization of ocular injury among U.S. Armed Forces

Article
2/1/2022
Air Force and Space Force Surgeon General Lt. Gen. Dorothy Hogg receives an eye exam from Air Force Reserve Maj. Leslie Wilderson at Joint Base Anacostia-Bolling, Washington, D.C., March 26, 2021. Photo By: Air Force Staff Sgt. Kayla White

Ocular injuries present an ongoing threat to readiness and retention of service members. This report describes a new approach to categorizing ocular injury using Military Health System data, the application of an algorithm to a dataset, and the verification of the results using an audit of clinical data.

Recommended Content:

Medical Surveillance Monthly Report

Surveillance snapshot: Health care burden attributable to osteoarthritis and spondylosis, active component, U.S. Armed Forces, 2016–2020

Article
2/1/2022
Air Force security forces trainees climb a hill during a 3-mile ruck march to commemorate National Police Week at Joint Base San Antonio, May 13, 2019. Photo By: Sarayuth Pinthong, Air Force

This snapshot summarizes the total numbers of inpatient and outpatient encounters with an OA or spondylosis diagnosis in the first diagnostic position and the total numbers of unique individuals affected by these conditions during the same 5-year surveillance period.

Recommended Content:

Medical Surveillance Monthly Report

Description of a COVID-19 Beta Variant Outbreak, Joint Base Lewis-McChord, WA, February–March 2021

Article
1/1/2022
U.S. Army Soldiers from 1-17th Infantry Battalion, 2nd Stryker Brigade, 2nd Infantry Division, clear an objective during the training exercise Bayonet Focus 19-02 at Yakima Training Center, Wash., May 6, 2019. Bayonet Focus is a training exercise designed to assess Soldiers’ ability to preform tasks and complete objectives under conditions experienced during combat situations. (U.S. Army photo by Spc. Angel Ruszkiewicz)

This report describes an outbreak of SARS-CoV-2, the causative agent of COVID-19, that peaked during 21–26 February 2021 and was tied to a single military training event. A total of 143 laboratory-confirmed cases were identified.

Recommended Content:

Medical Surveillance Monthly Report

COVID-19 and Depressive Symptoms Among Active Component U.S. Service Members, January 2019–July 2021

Article
1/1/2022
With the holiday season upon us, the cold, dark days that winter brings, and the social distancing and movement restrictions brought about by COVID-19, it’s not uncommon for people to feel depressed. (Photo by Erin Bolling)

This study examined the rates of depressive symptoms in active component U.S. service members prior to and during the COVID-19 pandemic and evaluated whether SARS-CoV-2 test results (positive or negative) were associated with self-reported depressive symptoms.

Recommended Content:

Medical Surveillance Monthly Report

Surveillance Snapshot: Lengths of Hospital Stays for Service Members Diagnosed with Sepsis, Active Component, U.S. Armed Forces, 2011–2020

Article
1/1/2022
The (left to right) Senior Airman Austin Shrewsbury, 88th Diagnostics and Therapeutic Squadron medical laboratory technician, works with student, Airman 1st Class Taylor Altman, 88th Diagnostics and Therapeutic Squadron medical laboratory technician, to identify bacteria of patient’s cultures inside the microbiology laboratory at Wright-Patterson Air Force Base medical center June 30, 2017.

Sepsis is a serious and life-threatening organ dysfunction caused by a dysregulated host response to infection. In the U.S., sepsis is a leading cause of in-hospital mortality and 1 of the most expensive conditions treated in U.S. hospitals.

Recommended Content:

Medical Surveillance Monthly Report

Incident COVID-19 Infections, Active and Reserve Components, Jan. 1, 2020–Aug. 31, 2021

Article
12/1/2021
U.S. Marines with Marine Rotational Force - Darwin receive a second COVID-19 test during quarantine on Royal Australian Air Force Base Darwin in Darwin, NT, Australia, June 12, 2020. The COVID-19 test was administered to each Marine after arriving from California. All Marines will be quarantined for 14 days and undergo an additional test before quarantine release. No Marines tested positive for COVID-19. The U.S. Marine Corps and Australian Defence Force service members are working together to ensure the safety of the local community. (U.S. Marine Corps photo by Lance Cpl. Natalie Greenwood)

Incident COVID-19 Infections, Active and Reserve Components, 1 January 2020–31 August 2021

Recommended Content:

Medical Surveillance Monthly Report

Surveillance Snapshot: Donovanosis Among Active Component Service Members, U.S. Armed Forces, 2011–2020

Article
12/1/2021
This photomicrograph of a tissue sample extracted from a lesion in the inguinal region of the female granuloma inguinale, or Donovanosis patient, depicted in PHIL 6431, revealed a white blood cell (WBC) that contained the pathognomonic finding of Donovan bodies, which were encapsulated, Gram-negative rods, representing the responsible bacterium Klebsiella granulomatis, formerly known as Calymmatobacterium granulomatis. Photo credit: CDC/ Susan Lindsley

Recommended Content:

Medical Surveillance Monthly Report

Update: Osteoarthritis and Spondylosis, Active Component, U.S. Armed Forces, 2016–2020

Article
12/1/2021
Osteoarthritis (OA) knee . film x-ray AP ( anterior - posterior ) and lateral view of knee show narrow joint space, osteophyte ( spur ), subchondral sclerosis, knee joint inflammation. Photo by: iStockPhoto

Osteoarthritis (OA), the most com­mon adult joint disease, is primarily a degenerative disorder of the entire joint organ, including the subchondral bone, synovium, and periarticular structures (e.g., tendons, ligaments, bursae). Spondylosis, often referred to as OA of the spine, is characterized by degenerative changes in the vertebral discs, joints, and vertebral bodies.

Recommended Content:

Medical Surveillance Monthly Report

Update: Plant Dermatitis Among Active Component Service Members, U.S. Armed Forces, 2010–2020

Article
11/1/2021
Poison ivy (Toxicodendron radicans)

Plant dermatitis is an allergic inflammatory skin reaction in response to the oils of poisonous plants. In the U.S., the most common dermatitis-causing plant genus is the Toxicodendron (formerly Rhus). Approximately 50%–75% of the U.S. adult population are susceptible to skin reactions upon exposure to Toxicodendron oil or oleoresin, called urushiol.

Recommended Content:

Medical Surveillance Monthly Report
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 16

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.